EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study

Ji-Hee Kim, Jae-Kyung Nam, Min-Sik Park, Seungyoul Seo, Hyung Chul Ryu, Hae-June Lee, Jeeyong Lee, Yoon-Jin Lee iD

International Journal of Molecular Sciences · 05.08.2025 · 26 (15) · 7570

DOI: 10.3390/ijms26157570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.08.2025. Verfasst von Ji-Hee Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea. Hauptthemen laut MEDLINE: Indoles, Macrophages, Idiopathic Pulmonary Fibrosis, Aminopyridines. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Ministry of Science and ICT (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with limited therapeutic options and increasing global incidence, with a median survival of only 2–5 years. The clinical utility of macrophage polarization to regulate the progression of pulmonary fibrosis remains understudied. This study determined the efficacy of nintedanib and pexidartinib (PLX3397) combination therapy for treating IPF. Combination treatment effectively inhibited the progression of radiation-induced pulmonary fibrosis (RIPF) and prolonged survival in bleomycin-treated mice. Micro-CT analysis revealed a significant tissue repair efficacy. The therapy significantly normalized the abnormal vascular structure observed during RIPF and bleomycin-induced pulmonary fibrosis progression and was accompanied by a decrease in the M2 population. Polarized M1 macrophages enhanced normalized tube formation of irradiated endothelial cells (ECs) in vitro; M2 macrophages increased adhesion in irradiated ECs and abnormal tube formation. Single-cell RNA sequencing data from patients with IPF further supports colony stimulating factor (CSF) 1 upregulation in macrophages and downregulation of capillary EC markers. This study highlights a promising combination strategy to overcome the therapeutic limitations of monotherapy with nintedanib for the treatment of IPF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesMacrophagesIdiopathic Pulmonary FibrosisAminopyridinesPyrrolesAnimalsMiceHumansDrug Therapy, CombinationBleomycinDisease Models, AnimalMaleMice, Inbred C57BLEndothelial Cells

Stichwörter der Autor:innen

PLX3397combination therapyidiopathic pulmonary fibrosisnintedanibpexidartinib

Substanzen

nintedanibIndolespexidartinibAminopyridinesPyrrolesBleomycin

Autor:innen und Institutionen

  • Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
  • Agathonbio Co., Ltd., Hwaseong-si 18487, Gyeonggi-do, Republic of Korea.
  • Independent Researcher, Hwaseong-si 18487, Gyeonggi-do, Republic of Korea.
  • College of Veterinary Medicine, Jeju National University, Jeju 63243, Republic of Korea.

ORCID-Profile: Yoon-Jin Lee

Förderung

  • National Research Foundation
  • Ministry of Science and ICT (MSIT)

Zitieren

APA

Kim, J. H., Nam, J. K., Park, M. S., Seo, S., Ryu, H. C., Lee, H. J., Lee, J., & Lee, Y. J. (2025). Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study. International Journal of Molecular Sciences, 26(15), 7570. https://doi.org/10.3390/ijms26157570

Vancouver

Kim JH, Nam JK, Park MS, Seo S, Ryu HC, Lee HJ, et al. Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study. International Journal of Molecular Sciences. 2025;26(15):7570. doi:10.3390/ijms26157570

BibTeX
@article{Kim2025,
  author = {Kim, Ji-Hee and Nam, Jae-Kyung and Park, Min-Sik and Seo, Seungyoul and Ryu, Hyung Chul and Lee, Hae-June and Lee, Jeeyong and Lee, Yoon-Jin},
  title = {Pexidartinib and Nintedanib Combination Therapy Targets Macrophage Polarization to Reverse Pulmonary Fibrosis: A Preclinical Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7570},
  doi = {10.3390/ijms26157570}
}
Kostenlos starten →